Governing Human Germline Editing Through Patent Law

September 28, 2021, Vol 326, No. 12, Pages 1133-1222


Governing Human Germline Editing Through Patent Law
Jacob S. Sherkow, JD, MA; Eli Y. Adashi, MD, MS; I. Glenn Cohen, JD
JAMA. 2021;326(12):1149-1150. doi:10.1001/jama.2021.13824
This Viewpoint discusses ethical considerations and use of patents for human germline editing in the context of a recent World Health Organization report and release of several auxiliary documents exploring international governance tools for human genome engineering.